Hosted by IDTechEx
Global Biotechnology Insights
Truly Global Daily News Interpreted by Experts
HomeEventsReportsTVCareersAbout UsSign-up or LoginIDTechExTwitterFacebookLinkedInGoogle+YoutubeRSSForward To Friend

Pharmaceutical

Global Biotechnology Insights
Development of opioid alternatives

Development of opioid alternatives

Mar 7, 2018 United Kingdom
Researchers have identified how the brain's natural painkilling system could be used as a possible alternative to opioids for the effective relief of chronic pain, which affects as many as one in three people at some point in their lives.
Global Biotechnology Insights
Sea anemone sting cells could inspire new drug-delivery systems

Sea anemone sting cells could inspire new drug-delivery systems

Feb 23, 2018 Europe
A multi-stage genetic process for the formation of sting cells in sea anemones could inspire a new way of delivering drugs into the human body.
Global Biotechnology Insights
FDA approves first digital pill

FDA approves first digital pill

Dec 11, 2017 United States
FDA approves Abilify MyCite, a pill with a sensor that digitally tracks if patients have ingested their medication
Global Biotechnology Insights
IDTechEx TVPrinted meds could reinvent pharmacies, drug research

Printed meds could reinvent pharmacies, drug research

Oct 2, 2017 United States
A new process can print multiple medications onto a single dissolvable strip, microneedle patch or other surface.
Global Biotechnology Insights
One vaccine injection could carry many doses

One vaccine injection could carry many doses

Sep 22, 2017 United States
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.
Global Biotechnology Insights
Dozens of new genes that create T cell-resistant cancer discovered

Dozens of new genes that create T cell-resistant cancer discovered

Aug 11, 2017 United States
To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.
Global Biotechnology Insights
Upconverted light has a bright future

Upconverted light has a bright future

Jul 25, 2017 United States
A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.
Global Biotechnology Insights
Personalized cancer vaccine

Personalized cancer vaccine

Jul 14, 2017 United States
A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.
Global Biotechnology Insights
Strategic drug discovery collaboration

Strategic drug discovery collaboration

Jul 10, 2017 United Kingdom
Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.
Global Biotechnology Insights
Nanoparticles breathe new life into doxorubicin cancer treatment

Nanoparticles breathe new life into doxorubicin cancer treatment

Jun 16, 2017 Worldwide
Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.